Amphetamine salts and Adderall are the same medication. “Adderall” is the brand name, and “amphetamine salts” or “mixed amphetamine salts” (often abbreviated MAS) is the generic name that appears on pharmacy labels when you receive a non-brand version. The active ingredients, their proportions, and their intended effects are identical. The confusion is understandable, though, because few other medications have such a clinical-sounding generic name, and the shift from a familiar brand name to an unfamiliar chemical label on your pill bottle can feel like you’ve been given something different.
What Is Actually in the Pill
Adderall contains a specific blend of four amphetamine salts: amphetamine aspartate monohydrate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate. These four salts are combined in equal parts by weight. The result is a mixture that delivers roughly 75% dextroamphetamine (the “d-” form) and 25% levoamphetamine (the “l-” form). This three-to-one ratio is not accidental. Dextroamphetamine is the more pharmacologically potent of the two mirror-image forms, but including some levoamphetamine broadens the medication’s effects on norepinephrine, which contributes to sustained attention and arousal.
When your pharmacy fills a generic prescription, the label will typically read “amphetamine salts” or “mixed amphetamine salts” followed by the dose. That label refers to the same four-salt blend. The FDA requires that generic medications contain the same active ingredients in the same amounts and reach the same blood levels as the brand-name drug within a narrow range. So while the pill’s color, shape, or inactive ingredients (fillers, binders, dyes) can differ between manufacturers, the active drug profile is the same.
Why Your Prescription Might Say Something Different
If you’ve been prescribed Adderall for years and suddenly your bottle says “amphetamine salts combo” or “d-amphetamine salt combo,” it can feel like the pharmacist made a mistake. This usually happens for one of two reasons. First, your insurance may have switched you to a generic formulation, which is dispensed under the chemical name rather than the brand. Second, your prescriber may have written the prescription using the generic name, which is increasingly common and often required by insurance plans.
The distinction matters to pharmacists and insurers, but not to your body. Think of it like ibuprofen and Advil. No one worries that “ibuprofen” is a different drug from Advil; they just recognize it as the non-brand version. The same logic applies here. “Mixed amphetamine salts 20 mg” and “Adderall 20 mg” describe the same chemical payload.
That said, some people notice subjective differences when switching between brand-name Adderall and a generic version from a different manufacturer. This is typically attributed to minor variations in inactive ingredients affecting how the tablet dissolves, though no large-scale clinical trials have shown consistent pharmacological differences between properly manufactured generics and the brand. Still, the experience is real enough to individual patients that prescribers sometimes specify “dispense as written” for brand-name Adderall when someone reports problems with a particular generic.
Immediate-Release vs. Extended-Release
Both Adderall and its generic come in two formulations: immediate-release (IR) and extended-release (XR). The immediate-release version is a standard tablet that delivers all of its amphetamine salts at once, reaching peak blood levels in about three hours and lasting roughly four to six hours. It’s often prescribed to be taken twice a day.
The extended-release capsule, branded as Adderall XR, uses a bead-delivery system. Each capsule contains two types of beads: half release immediately, and half have a delayed-release coating that dissolves later. This produces two pulses of medication, mimicking the effect of taking two IR doses about four hours apart. The result is a smoother, longer-lasting effect that can cover a full school or work day with a single morning dose.
Generic extended-release versions are labeled “amphetamine salts XR” or “mixed amphetamine salts ER.” They use the same dual-bead approach and are required to demonstrate equivalent drug delivery to brand-name Adderall XR. The pharmacokinetic profile in adolescents shows that peak blood levels and overall drug exposure are influenced by age and body weight, with younger or lighter patients tending to reach higher peak concentrations from the same dose.1Cambridge University Press / CNS Spectrums. Pharmacokinetics of Mixed Amphetamine Salts Extended Release in Adolescents With ADHD Gender, on the other hand, did not affect how the drug was processed.
How It Works in the Brain
Regardless of whether the bottle says “Adderall” or “amphetamine salts,” the medication works through the same mechanism. Amphetamine increases the levels of dopamine and norepinephrine in the spaces between nerve cells. It does this in two ways: it blocks the transporter proteins that normally vacuum these chemicals back into the sending neuron, and it also causes those transporters to work in reverse, actively pushing dopamine and norepinephrine out into the synapse.2PubMed Central. The Pharmacology of Amphetamine and Methylphenidate: Relevance to the Neurobiology of Attention-Deficit/Hyperactivity Disorder and Other Psychiatric Comorbidities The net effect is a significant boost in dopamine and norepinephrine signaling, particularly in the prefrontal cortex, which governs attention, impulse control, and working memory.
The two isomers in the mix contribute slightly different profiles. Dextroamphetamine has a stronger effect on the dopamine system, which is more closely linked to motivation, focus, and reward. Levoamphetamine has a proportionally stronger effect on norepinephrine, contributing to alertness and sustained attention. The blend in Adderall was designed to produce a broader clinical effect than pure dextroamphetamine alone, and many clinicians and patients report that the combination feels smoother or more balanced, though the evidence for a meaningful difference over pure dextroamphetamine is debated.
Clinical Effectiveness
The mixed amphetamine salts formulation has been studied in both children and adults with ADHD, and the results are consistently strong. In a controlled trial of adults, treatment with mixed amphetamine salts at an average dose of about 54 mg per day, split into two doses, led to a 42% decrease in ADHD symptom scores. Seventy percent of adults on the medication showed meaningful improvement, compared to just 7% on placebo.3JAMA Network. Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder That response rate is among the highest seen in ADHD medication trials.
In children, the medication has similarly demonstrated clear benefits over placebo for core ADHD symptoms including inattention, hyperactivity, and impulsivity.4Pediatrics. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects The most commonly reported side effects across studies include decreased appetite, difficulty falling asleep, and mild increases in heart rate or blood pressure. These are properties of the amphetamine itself, not of the brand formulation, and they occur equally with generic versions.
Why Urine pH Can Change How Long It Lasts
One underappreciated factor in how amphetamine salts behave is urinary pH. Amphetamine is a basic compound, and the kidneys excrete it faster when urine is acidic. In acidic urine, more of the drug is in its charged, water-soluble form, so the kidneys dump it out efficiently. In alkaline urine, more of the drug stays in its uncharged form, gets reabsorbed back into the blood from the kidney tubules, and stays in the body longer. Modeling studies have confirmed that changes in urine pH can dramatically alter both how much drug the kidneys clear and how much total drug exposure the body gets.5Europe PMC. Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine
In practical terms, this means that things like your diet, antacid use, and even urinary tract infections can shift how long a dose of Adderall or its generic equivalent lasts. High doses of vitamin C or acidic beverages may slightly shorten the duration, while sodium bicarbonate (baking soda) or a diet heavy in alkaline foods could prolong it. This is not a dramatic hour-by-hour effect for most people, but it helps explain why the same dose can feel slightly different from one day to the next, independent of whether you are taking brand or generic.
Uses Beyond ADHD
While ADHD is by far the most common reason people encounter amphetamine salts, the medication is also FDA-approved for narcolepsy. Amphetamine has been used to treat excessive daytime sleepiness and sudden sleep attacks since the early twentieth century. It remains effective for this purpose, though it is no longer the first choice. Modafinil has largely replaced both amphetamine and methylphenidate as the preferred treatment for narcolepsy-related sleepiness, primarily because it carries a lower risk of dependence and cardiovascular side effects.6Europe PMC. Narcolepsy: current treatment options and future approaches Amphetamine is still used when modafinil alone isn’t enough or when a patient’s sleepiness is particularly severe.
Off-label, clinicians sometimes prescribe amphetamine salts for treatment-resistant depression, particularly when fatigue and low motivation are prominent features. This use is less well studied and carries meaningful risks, so it tends to be reserved for situations where standard antidepressants have failed.
Abuse Potential and Why It’s Tightly Controlled
All amphetamine-based medications, whether branded as Adderall or dispensed as generic amphetamine salts, are classified as Schedule II controlled substances in the United States. This is the same scheduling category as oxycodone and morphine, reflecting the drug’s recognized medical value alongside a high potential for misuse and dependence. The scheduling is identical for brand and generic. There is no regulatory distinction between them from a controlled-substance standpoint.
The abuse risk is inherent to the amphetamine molecule, not the formulation name. At therapeutic doses taken as prescribed for ADHD, the risk of developing a substance use disorder is relatively low, but amphetamines have been widely misused since they were first introduced in the 1930s. A review of the evidence highlighted that while amphetamine stimulants have long been used effectively for ADHD, they carry high abuse potential and can be neurotoxic at sustained high doses, raising concern about the expanding use of these medications as long-term maintenance therapy in adults.7Europe PMC / Nature Publishing Group. Potential adverse effects of amphetamine treatment on brain and behavior: a review
The extended-release formulation is sometimes considered to carry a slightly lower abuse risk than the immediate-release version, because the slow delivery of medication makes it harder to get a rapid “rush.” Crushing the beads defeats this, though, which is why newer stimulant formulations (like lisdexamfetamine, marketed as Vyvanse) were specifically engineered to require metabolic activation in the body, making them harder to abuse by snorting or injection. Amphetamine salts, whether brand or generic, do not have this built-in abuse-deterrent property.
How Age and Body Weight Affect the Medication
Pharmacokinetic studies of the extended-release formulation in adolescents reveal that age and body weight meaningfully influence drug levels. Peak blood concentrations tend to be higher in younger, lighter patients taking the same milligram dose, while the drug’s half-life increases with age.1Cambridge University Press / CNS Spectrums. Pharmacokinetics of Mixed Amphetamine Salts Extended Release in Adolescents With ADHD This means a 12-year-old weighing 90 pounds and an 18-year-old weighing 170 pounds can experience very different drug exposures on the same prescribed dose. The total amount of drug the body absorbs over time stays roughly the same regardless of age, but the peak and duration shift, which affects both how intensely the medication kicks in and how long it lasts.
These findings apply to both brand-name Adderall XR and generic amphetamine salts XR, since the active ingredient and delivery mechanism are the same. For clinicians, this data reinforces the importance of weight-based dose adjustments in younger patients and explains why a dose that worked perfectly at age 13 may feel different by age 17 without any change in the prescription.
The Shortage Problem
If you’ve tried to fill a prescription for amphetamine salts in recent years, you may have run into shortages. Since 2022, the United States has experienced intermittent supply disruptions for both brand-name and generic amphetamine salt products. These shortages result from a combination of factors: DEA production quotas that cap how much amphetamine active ingredient manufacturers can produce each year, surging demand driven by increased ADHD diagnoses (particularly in adults), and manufacturing bottlenecks at specific generic drug facilities.
During shortages, patients are sometimes switched between manufacturers or between IR and XR formulations. While the active drug content is equivalent, different manufacturers’ tablets can vary in size, shape, coating, and filler materials. For most people, these differences are meaningless. But for patients who are sensitive to a particular filler, or who rely on a specific onset and duration profile, switching manufacturers involuntarily can be disruptive. Pharmacists can sometimes help by contacting alternative suppliers or checking whether a different manufacturer’s version is in stock, but during acute shortages, options narrow quickly. This is one of the few situations where the practical distinction between “Adderall” and “amphetamine salts” matters, not because the drug is different, but because your pharmacy’s ability to fill one version versus another may depend on which manufacturers currently have supply.